ASTE1 and colorectal cancer: When ASTE1 is down-regulated or mutated (e.g., in 80% of colorectal cancers), it no longer prevents the formation of the ATP2C1 isoforms-b, c and d, which are less sensitive to miRNA-mediated inhibition.